Prevention of immunoglobulin E production as a therapeutic target

被引：1
|
作者：
Woisetschläger, M [1 ]
Stütz, AM [1 ]
Ettmayer, P [1 ]
机构：
[1] Novartis Forschungsinst, Dept Allerg Dis, A-1230 Vienna, Austria
来源：
DRUG NEWS & PERSPECTIVES | 2002年 / 15卷 / 02期
关键词：
D O I：
10.1358/dnp.2002.15.2.704649
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Immunoglobulin E (IgE) has been known for quite some years to be critically involved in the initiation of a number of allergic diseases. Its importance as therapeutic target was confirmed and strengthened by recent evidence that neutralizing monoclonal antibodies directed against IgE showed clinical efficacy in large clinical trials with patients suffering from asthma and allergic rhinitis. These data, for the first time, confirmed the predictions made from results obtained in numerous animal studies. This contribution discusses the importance of IgE as therapeutic target in allergic diseases with special emphasis on approaches aimed at inhibiting IgE synthesis by B-lymphocytes. (C) 2002 Prous Science. All rights reserved.
引用
收藏
页码：78 / 84
页数：7
相关论文
共 50 条
  • [1] THE IMMUNOGLOBULIN-E RECEPTOR - THERAPEUTIC PERSPECTIVES
    KINET, JP
    SEMAINE DES HOPITAUX, 1991, 67 (26-27): : 1201 - 1203
  • [2] Immunoglobulin E production in chronic pancreatitis
    Raithel, M
    Dormann, H
    Harsch, IA
    Winterkamp, S
    Weidenhiller, M
    Fischer, B
    Hahn, EG
    Schneider, T
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (07) : 801 - 807
  • [3] Prevention of Ankylosis: A Specific Therapeutic Target in Spondyloarthritis
    Lories, Rik J. U.
    de Vlam, Kurt
    CURRENT RHEUMATOLOGY REVIEWS, 2007, 3 (04) : 317 - 321
  • [4] Myeloperoxidase: A promising therapeutic target in prevention of atherosclerosis
    Long, Lili
    Song, Yanmin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 256 : 15 - 15
  • [5] AMPK: Therapeutic Target for Diabetes and Cancer Prevention
    Umezawa, Shotaro
    Higurashi, Takuma
    Nakajima, Atsushi
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (25) : 3629 - 3644
  • [6] Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention
    Ossoli, Alice
    Pavanello, Chiara
    Giorgio, Eleonora
    Calabresi, Laura
    Gomaraschi, Monica
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (09) : 1610 - 1630
  • [7] Disodium cromoglycate inhibits production of immunoglobulin E
    Seo, SB
    Park, SJ
    Park, ST
    Cho, CC
    Park, BH
    Lee, SJ
    Kim, HM
    Kajiuchi, T
    Shin, TY
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2001, 23 (02) : 229 - 237
  • [8] Bronchial immunoglobulin E production in intrinsic asthma
    Humbert, M
    REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 2003, 43 (04): : 229 - 231
  • [9] THE MUSCULOSKELETAL SYSTEM AS A NEW THERAPEUTIC TARGET IN FRACTURE PREVENTION
    Grigorie, D.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2013, 9 (01) : 87 - 88
  • [10] Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis?
    Simonato, Michele
    Zucchini, Silvia
    EPILEPSIA, 2010, 51 : 48 - 51
12345